AmorChem recently announced the financing of a project in the laboratory of Jasna Kriz which aims to develop new therapeutic avenues for Amyotrophic Lateral Sclerosis (ALS) and other neuroinflammatory diseases. Following an agreement between Université Laval and the CERVO Brain Research Centre (CIUSSS-CN), the venture capital fund AmorChem will invest in a project which targets a molecule, called SRSF3, which is involved in regulation of innate immunity.
Read an article in La Presse reporting how research by professor Marc Hébert, of the CERVO Brain Research Centre, has led to an invention to fight tiredness at the wheel.
Fatigue at the wheel kills tens of Quebecers every year, and injures thousands more. To combat this scourge, a researcher at Université Laval and a technological investor joined forces to develop an invention.
The idea: using the infamous blue light which undermines sleep when we watch our screens before bed to stimulate awareness of drivers.
Jean-Pierre Julien's team recently published an article in the high impact journal, the Journal of Clinical Investigations, about a new experimental therapy for ALS and frontotemporal dementia based on the use of antibodies that target the abnormal accumulation of a protein called TDP-43 in degenerating neurons. The formation of TDP-43 aggregates is associated with ALS development.
A study published in Health reports, a publication of Statistics Canada, shows prevalence of insomnia went from 17% te 24% between 2007 and 2015.
Read a summary of the main discoveires in an article in LeFil from l'Université Laval:
The full article in Health reports is available on the Statistics Canada website:
Visit our new videos page, where you will find interviews and reports with CERVO researchers, scientific animations, scientific presentations and promotional videos for the PhD@CERVO program. We also invite our researchers to send us videos to include in CERVOTube!
In a recent article in La Presse newspaper, Dr. Michel Maziade highlights the importance of recognizing brain diseases as such, as the Verreault family has done on the occasion of a "non-anonymous" $1M dollar donation for research on brain diseases. It is time, says professor Maziade, to name the three main psychiatric brain diseases, schizophrenia, bipolar disorder and major depression, as they affect 4% of the population, or 1 million people in Canada alone. Dr.
A discovery by Caroline Ménard published this year in Nature Neuroscience is amongst the top 10 discoveries of 2018 according to the scientific magazine Québec Science. Read the article by Martine Letarte «Le lien entre stress et dépression mis au jour» which explains this important discovery by Dr. Ménard, a researcher at the CERVO Brain Research Centre.
A research team including many researchers from the CERVO Brain Research Centre and Université Laval just published a new machine learning approach to optimize super-resolution microscopy images. The researchers published this important innovation in the prestigious journal Nature Communications, and made the tool available online for the scientific community by publishing their code.
Read a recent article in Le Fil on the work of Majid Ghareghani, who recently joined Armen Saghatelyan's team as a PhD student at the CERVO brain research center
Majid Ghareghani is first author of an article recently published in Frontiers in Immunology which proposes a new hypothesis to explain the cascade of events leading to multiple sclerosis.
Read the article in Le Fil: Une nouvelle piste pour la sclérose en plaques